These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7310593)

  • 1. Relative bioavailability of intravenous chloramphenicol succinate and oral chloramphenicol palmitate in infants and children.
    Kauffman RE; Thirumoorthi MC; Buckley JA; Aravind MK; Dajani AS
    J Pediatr; 1981 Dec; 99(6):963-7. PubMed ID: 7310593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative bioavailability of intravenous and oral chloramphenicol in adults.
    Kramer WG; Rensimer ER; Ericsson CD; Pickering LK
    J Clin Pharmacol; 1984 Apr; 24(4):181-6. PubMed ID: 6725619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bioavailability and pharmacokinetics of chloramphenicol after intravenous chloramphenicol succinate in premature infants and older patients.
    Nahata MC; Powell DA
    Dev Pharmacol Ther; 1983; 6(1):23-32. PubMed ID: 6839912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of two chloramphenicol preparations in children: sodium succinate (iv) and palmitate (oral) esters.
    Pickering LK; Hoecker JL; Kramer WG; Kohl S; Cleary TG
    J Pediatr; 1980 Apr; 96(4):757-61. PubMed ID: 6987361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.
    Ambrose PJ
    Clin Pharmacokinet; 1984; 9(3):222-38. PubMed ID: 6375931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability and clearance of chloramphenicol after intravenous chloramphenicol succinate.
    Nahata MC; Powell DA
    Clin Pharmacol Ther; 1981 Sep; 30(3):368-72. PubMed ID: 7273601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of chloramphenicol palmitate in neonates.
    Shankaran S; Kauffman RE
    J Pediatr; 1984 Jul; 105(1):113-6. PubMed ID: 6737126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and children.
    Kauffman RE; Miceli JN; Strebel L; Buckley JA; Done AK; Dajani AS
    J Pediatr; 1981 Feb; 98(2):315-20. PubMed ID: 7463235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intravenous chloramphenicol sodium succinate in adult patients with normal renal and hepatic function.
    Burke JT; Wargin WA; Sherertz RJ; Sanders KL; Blum MR; Sarubbi FA
    J Pharmacokinet Biopharm; 1982 Dec; 10(6):601-14. PubMed ID: 7182457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloramphenicol serum concentration falls during chloramphenicol succinate dosing.
    Nahata MC; Powell DA
    Clin Pharmacol Ther; 1983 Mar; 33(3):308-13. PubMed ID: 6825386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of chloramphenicol sodium succinate after intramuscular administration in children.
    Shann F; Linnemann V; Mackenzie A; Barker J; Gratten M; Crinis N
    N Engl J Med; 1985 Aug; 313(7):410-4. PubMed ID: 4022068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloramphenicol succinate pharmacokinetics in Macaca nemestrina: dose dependency study.
    Koup JR; Weber A; Smith AL
    J Pharmacol Exp Ther; 1981 Nov; 219(2):316-20. PubMed ID: 7288623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloramphenicol dosage and pharmacokinetics in infants and children.
    Burckart GJ; Barrett FF; Della Valle R; Meyer MC
    J Clin Pharmacol; 1983; 23(2-3):106-12. PubMed ID: 6853742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic interactions among chloramphenicol, phenytoin and phenobarbital.
    Krasinski K; Kusmiesz H; Nelson JD
    Pediatr Infect Dis; 1982; 1(4):232-5. PubMed ID: 7177912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloramphenicol concentrations in sera of patients with typhoid fever being treated with oral or intravenous preparation.
    Ti TI; Monteiro EH; Lam S; Lee HS
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1809-11. PubMed ID: 2285296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravenous flow rate and injection site on in vitro delivery of chloramphenicol succinate and in vivo kinetics.
    Nahata MC; Powell DA; Glazer JP; Hilty MD
    J Pediatr; 1981 Sep; 99(3):463-6. PubMed ID: 7264810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloramphenicol succinate kinetics in infants and young children.
    Sack CM; Koup JR; Opheim KE; Neeley N; Smith AL
    Pediatr Pharmacol (New York); 1982; 2(2):93-103. PubMed ID: 12760401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and pharmacokinetics of chloramphenicol palmitate in malnourished children.
    Mahta S; Nain CK; Kalsi HK; Mathur VS
    Indian J Med Res; 1981 Aug; 74():244-50. PubMed ID: 6796509
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis.
    Tuomanen EI; Powell KR; Marks MI; Laferriere CI; Altmiller DH; Sack CM; Smith AL
    J Pediatr; 1981 Dec; 99(6):968-74. PubMed ID: 6975811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bioavailability of chloramphenicol palmitate suspension].
    Morasso MI; Hirmas E; Firmani E; Pezoa R; Cid E
    Pharm Acta Helv; 1980; 55(10):270-3. PubMed ID: 7454734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.